News + Filings Transactions Holdings
|
Bain Capital Life Sciences Investors, LLC
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/25/2023 | Annexon, Inc. | ANNX | Purchase | Common Stock | 300k | $2.13 | $639.7k | See footnotes | 05/25/2023 |
12/10/2021 | Xilio Therapeutics, Inc. | | Purchase | Common Stock | 21.8k | $9.56 | $208.6k | See footnotes | 12/08/2021 |
12/10/2021 | Xilio Therapeutics, Inc. | | Purchase | Common Stock | 3.2k | $10.24 | $32.6k | See footnotes | 12/08/2021 |
12/09/2021 | Xilio Therapeutics, Inc. | | Purchase | Common Stock | 4k | $9.84 | $39.5k | See footnotes | 12/08/2021 |
12/08/2021 | Xilio Therapeutics, Inc. | | Purchase | Common Stock | 13.5k | $9.62 | $129.5k | See footnotes | 12/08/2021 |
08/10/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 1000k | $70.25 | $70.2M | See footnotes | 08/10/2021 |
07/19/2021 | RAPID MICRO BIOSYSTEMS, INC. | RPID | Conversion | Series C1 Preferred Stock | 6.7M | $0.00 | $0 | See footnotes | 07/19/2021 |
07/19/2021 | RAPID MICRO BIOSYSTEMS, INC. | RPID | Conversion | Series B1 Preferred Stock | 35M | $0.00 | $0 | See footnotes | 07/19/2021 |
07/19/2021 | RAPID MICRO BIOSYSTEMS, INC. | RPID | Purchase | Class A Common Stock | 100k | $20.00 | $2M | See footnotes | 07/19/2021 |
07/19/2021 | RAPID MICRO BIOSYSTEMS, INC. | RPID | Conversion | Class A Common Stock | 1.3M | $0.00 | $0 | See footnotes | 07/19/2021 |
07/19/2021 | RAPID MICRO BIOSYSTEMS, INC. | RPID | Conversion | Class A Common Stock | 7M | $0.00 | $0 | See footnotes | 07/19/2021 |
03/09/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 1.4M | $71.50 | $103.7M | See Footnotes | 03/09/2021 |
10/26/2020 | Aptinyx Inc. | APTX | Purchase | Common Stock | 3.3M | $3.00 | $10M | See footnotes | 10/26/2020 |
07/28/2020 | Annexon, Inc. | ANNX | Conversion | Common Stock | 2.5M | $0.00 | $0 | See Footnotes | 07/28/2020 |
07/28/2020 | Annexon, Inc. | ANNX | Conversion | Common Stock | 319.2k | $0.00 | $0 | See Footnotes | 07/28/2020 |
07/28/2020 | Annexon, Inc. | ANNX | Purchase | Common Stock | 400k | $17.00 | $6.8M | See Footnotes | 07/28/2020 |
07/28/2020 | Annexon, Inc. | ANNX | Conversion | Series C Preferred Stock | 22.2M | $0.00 | $0 | See Footnotes | 07/28/2020 |
07/28/2020 | Annexon, Inc. | ANNX | Conversion | Series D Preferred Stock | 2.8M | $0.00 | $0 | See Footnotes | 07/28/2020 |
02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Common Stock | 2.8M | $0.00 | $0 | See Footnotes | 02/04/2020 |
02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Common Stock | 859.6k | $0.00 | $0 | See Footnotes | 02/04/2020 |
02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Purchase | Common Stock | 294.1k | $17.00 | $5M | See Footnotes | 02/04/2020 |
02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Series B Preferred Stock | 2.8M | $0.00 | $0 | See Footnotes | 02/04/2020 |
02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Series C Preferred Stock | 859.6k | $0.00 | $0 | See Footnotes | 02/04/2020 |
11/19/2019 | Dicerna Pharmaceuticals Inc | DRNA | Sale | Common Stock | 1.8M | $22.03 | $38.6M | See Footnotes | 11/19/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 6.1M | $0.00 | $0 | See Footnotes | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 1.1M | $0.00 | $0 | See Footnotes | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Purchase | Common Stock | 150k | $18.00 | $2.7M | See Footnotes | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series A Convertible Preferred Stock | 6.1M | $0.00 | $0 | See Footnotes | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series B Convertible Preferred Stock | 1.1M | $0.00 | $0 | See Footnotes | 09/17/2019 |
05/29/2019 | Dicerna Pharmaceuticals Inc | DRNA | Sale | Common Stock | 1.6M | $12.50 | $20M | See footnotes | 05/29/2019 |
07/24/2018 | Replimune Group, Inc. | REPL | Conversion | Common Stock | 2.3M | $0.00 | $0 | See Footnotes | 07/24/2018 |
07/24/2018 | Replimune Group, Inc. | REPL | Purchase | Common Stock | 500k | $15.00 | $7.5M | See Footnotes | 07/24/2018 |
07/24/2018 | Replimune Group, Inc. | REPL | Conversion | Series B Convertible Preferred Stock | 235.1k | $0.00 | $0 | See footnotes | 07/24/2018 |
12/19/2017 | MARINUS PHARMACEUTICALS, INC. | MRNS | Sale | Common Stock | 94.8k | $7.62 | $722.2k | See footnotes | 12/15/2017 |
12/19/2017 | MARINUS PHARMACEUTICALS, INC. | MRNS | Sale | Common Stock | 55.2k | $7.11 | $392.4k | See footnotes | 12/15/2017 |
|
|